跳至主要内容
临床试验/NCT04851951
NCT04851951已完成不适用

Clinical Results Of Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis, Our Experience At Short-Term Follow Up

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
Change in Visual Analogic Scale

研究概览

简要总结

It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection), T2 (three months after the last injection) and T3 (six months after the last injection).

Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue Scale (VAS) were administered at each evaluation.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old;
  • Supraspinatus tendinosis detected by MRI.

排除标准

  • Supraspinatus rupture;
  • Previous shoulder surgery;
  • Rotator cuff tears secondary to fracture;
  • Hemoglobin <7 g/dL or Platelets < 30,000 microL;
  • Active infection;
  • Pregnant patients;
  • Patients with hematologic and oncologic diseases.

结局指标

主要结局

Change in Visual Analogic Scale

时间窗: Day 0; Month 1; Month 3; Month 6 (after the injection)

The shoulder pain was quantified using the Visual Analogic Scale ranging from 0 (no pain) to 10 (worst imaginable pain).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验